跳到正文

Avoro Capital Advisors LLC 13F 持仓 · 2026年Q2

Avoro Capital Advisors 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 26 只证券,申报市值合计 111.36 亿美元。前几大持仓:UTHR(13.52%)、ASND(12.24%)、KRYS(9.64%)。本季前 25 大持仓中:新建仓 3 只、增持 9 只、减持 4 只。

排名代码公司市值占组合股数变动
1UTHRUNITED THERAPEUTICS CORP$1.51B13.52%2.8M减持
2ASNDASCENDIS PHARMA$1.36B12.24%5.1M新建仓
3KRYSKRYSTAL BIOTECH INC$1.07B9.64%2.9M持平
4MDGLMADRIGAL PHARMACEUTICALS INC$984.4M8.84%1.8M增持
5ARGXARGENX SE$927.8M8.33%1.0M持平
6ARWRARROWHEAD PHARMACEUTICALS INC$925.6M8.31%11.4M增持
7KYMRKYMERA THERAPEUTICS INC$857.1M7.70%7.5M持平
8RVMDREVOLUTION MEDICINES INC$430.2M3.86%2.3M减持
9CYTKCYTOKINETICS INC$425.9M3.82%5.0M增持
10CELCCELCUITY INC$355.7M3.19%3.4M减持
11GPCRSTRUCTURE THERAPEUTICS INC$351.8M3.16%6.6M持平
12XENEXENON PHARMACEUTICALS INC$348.7M3.13%5.8M持平
13DFTXDEFINIUM THERAPEUTICS INC$338.2M3.04%7.2M增持
14QUREUNIQURE NV$309.9M2.78%6.7M增持
15VERAVERA THERAPEUTICS INC$245.6M2.21%5.7M减持
16TSHATAYSHA GENE THERAPIES INC$162.7M1.46%23.9M增持
17OCULOCULAR THERAPEUTIX INC$123.1M1.11%12.5M增持
18DMRADAMORA THERAPEUTICS INC$98.4M0.88%3.8M持平
19COAGHEMAB THERAPEUTICS HLDGS INC$70.7M0.63%1.9M新建仓
20GHRSGH RESEARCH PLC$48.4M0.43%1.8M持平
21VRDNVIRIDIAN THERAPEUTICS INC$45.9M0.41%2.5M增持
22SEPNSEPTERNA INC$44.8M0.40%1.3M持平
23AVTXAVALO THERAPEUTICS$43.1M0.39%2.3M增持
24FTHFAETH THERAPEUTICS INC$36.1M0.32%1.4M新建仓
25WHWKWHITEHAWK THERAPEUTICS INC$13.1M0.12%2.8M持平

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR